Centrexion
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of chronic pain... Read moreCentrexion
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of chronic pain... Read more
News
Nov 14, 2023
SEC
Centrexion: CENTREXION Received $2.3M in Debt Funding
May 24, 2022
SEC
Centrexion Therapeutics: CENTREXION Received $16.5M in Debt Funding
Oct 29, 2020
Boston Citybizlist
Centrexion Therapeutics: Centrexion Therapeutics Raises $40.5 Million
Nov 08, 2019
Benzinga
Centrexion Therapeutics: Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 American College of Rheumatology Annual Meeting and the 2019 American Academy of Physical Medicine and Rehabilitation Annual Assembly
Sep 19, 2019
FierceBiotech
Centrexion Therapeutics: Kindler's Centrexion restarts IPO bid to fund phase 3 pain trial
Sep 04, 2019
GlobeNewswire
Press Release: Centrexion Therapeutics : CORRECTION - Centrexion Therapeutics
Sep 04, 2019
Benzinga
Centrexion Therapeutics: Centrexion Therapeutics Announces CNTX-4975, CNTX-0290 and CNTX-6970 Data Presentations at PAINWeek 2019 National Conference
Jul 18, 2019
GlobeNewswire
Press Release: Centrexion Therapeutics : Centrexion Therapeutics to Present New Positive Clinical Trial Results on Streamlined CNTX-4975 Administration Techniques
Jun 17, 2019
BioPortfolio
Centrexion Therapeutics: Lilly to acquire nonopioid pain asset from Centrexion Therapeutics
Jun 11, 2019
4-traders
Centrexion Therapeutics: Centrexion Therapeutics to Announce CNTX-4975 Trial Results at the European League Against Rheumatism's (EULAR) 2019 Annual European Congress of Rheumatology
Centrexion Competitors
1
2
3
4
5
6
7
8
9
10